These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9322139
1. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. Kesten S, Chaparro C, Scavuzzo M, Gutierrez C. J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139 [Abstract] [Full Text] [Related]
2. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. Sarahrudi K, Estenne M, Corris P, Niedermayer J, Knoop C, Glanville A, Chaparro C, Verleden G, Gerbase MW, Venuta F, Böttcher H, Aubert JD, Levvey B, Reichenspurner H, Auterith A, Klepetko W. J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212 [Abstract] [Full Text] [Related]
3. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. Dusmet M, Maurer J, Winton T, Kesten S. J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991 [Abstract] [Full Text] [Related]
4. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. Patterson GM, Wilson S, Whang JL, Harvey J, Agacki K, Patel H, Theodore J. J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521 [Abstract] [Full Text] [Related]
5. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome. Borro JM, Bravo C, Solé A, Usetti P, Zurbano F, Lama R, De la Torre M, Román A, Pastor A, Laporta R, Cifrián JM, Santos F. Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206 [Abstract] [Full Text] [Related]
6. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation. Sarahrudi K, Carretta A, Wisser W, Senbaklavaci O, Ploner M, Neuhauser P, Dobrovits M, Miwai Marta G, Papp A, Klepetko W. Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609 [Abstract] [Full Text] [Related]
7. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP. J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858 [Abstract] [Full Text] [Related]
9. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder? Burton CM, Iversen M, Mortensen J, Carlsen J, Andersen CB, Milman N, Scheike T. J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078 [Abstract] [Full Text] [Related]
12. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T. Transplantation; 2008 Jan 15; 85(1):36-41. PubMed ID: 18192909 [Abstract] [Full Text] [Related]
19. Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation. Revell MP, Lewis ME, Llewellyn-Jones CG, Wilson IC, Bonser RS. J Heart Lung Transplant; 2000 Dec 15; 19(12):1219-23. PubMed ID: 11124493 [Abstract] [Full Text] [Related]